Abstract
Eight-year follow-up evaluation and analysis of factors related to postoperative thyroid dysfunction were made in 216 patients with Graves’ disease treated by subtotal thyroidectomy. The postoperative status of thyroid function were as follows according to hypersensitive TSH level: 65 patients (30.1%) were euthyroid, 25 (11.5%) had overt hyperthyroidism requiring treatment, 14 (6.5%) had subclinical hyperthyroidism with normal thyroid hormone and suppressed TSH, 21 (9.8%) were overt hypothyroid requiring thyroid hormone replacement and 91 (41.1%) had latent hypothyroidism without hormone replacement. In order to know factors related to postoperative thyroid function, age, sex, preoperative levels of TSH receptor antibody (TRAb), thyroid antibody titers, degree of lymphocyte infiltration, duration of medical treatment, weight of the resected thyroid tissue and weight of the remnant thyroid tissue were determined. No factor except thyroid remnant and antimicrosomal antibody titer was related to postoperative thyroid function. The weight of remnant should be less than 6 g to avoid recurrent hyperthyroidism. As recurrence of hyperthyroidism was observed more than 5 yr after surgery, long follow-up is needed.
Similar content being viewed by others
References
Michie W., Beck J.S., Pollet J.E. Prevention and management of hypothyroidism after thyroidectomy for thyrotoxicosis. World J. Surg. 2:306, 1978.
Toft A.D., Irvine W.J., Sinclair L., Mcintosh D., Seth J., Cameron E.H.D. Thyroid function after surgical treatment of thyrotoxicosis. A report of 100 cases treated with propranolol before operation. N. Engl. J. Med. 298:643, 1978.
Hedley A.J., Bewsher P.D., Jones S.J., Khir A.S.M., Clements P., Matheson N.A., Gunn A. Late onset hypothyroidism after subtotal thyroidectomy for hyperthyroidism: implications for long term follow-up. Br. J. Surg. 70:740, 1983.
Makiuchi M., Miyakawa M., Sugenoya A., Furihata R. An evaluation of several prognostic factors in the surgical treatment for thyrotoxicosis. Surg. Gynecol. Obstet. 152:639, 1981.
Kasuga Y., Sugenoya A., Kobayashi S., Kaneko G., Masuda H., Fujimoto M., Iida F. Clinical evaluation of the response to surgical treatment of Graves’ disease. Surg. Gynecol. Obstet. 170:327, 1990.
Cusick E.L., Krukowski A.H., Matheson N.A. Outcome of surgery for Graves’ disease re-examined. Br. J.Surg. 74:780, 1987.
Jortso E., Lennquist S., Lundstrom B., Norrby K., Smeds S. The influence of remnant size, antithyroid antibodies, thyroid morphology, and lymphocyte infiltration on thyroid function after subtotal resection for hyperthyroidism. World J. Surg. 11:365, 1987.
Bradley E.L., Liechty R.D. Modified subtotal thyroidectomy for Graves’ disease: A two-institution study. Surgery 94:955, 1983.
Steel N.R., Taylor J.J., Young E.T., Farndon J.R., Holcombe M., Kendall-Taylor P. The effect of subtotal thyroidectomy with propranolol preparation on antibody activity in Graves’ disease. Clin. Endocrinol. (Oxf.) 26:97, 1987.
Hamada N., Ito K., Mimura T., Ishikawa N., Momotani N., Noh J., Hosoda Y., Morii H. Retrospective revaluation of the significance of thyroid microsomal antibody in the treatment of Graves’ disease. Acta Endocrinol. (Copenh.) 114:328, 1987.
van Welsum M., Feltkamp T.E.W., de Vries M.J., Docter R., van Zijl J., Hennemann G. Hypothyroidism after thyroidectomy for Graves’ disease: A search for an explanation. Br. Med. J. 4:755, 1974.
Whitesell F.B. Jr., Black B.M. A statistical study of the clinical significance of lymphocytic and fibrocytic replacements in the hyperplastic thyroid gland. J. Clin. Endocrinol. Metab. 9:1202, 1949.
Busnardo B., Cirelli M.E., Rubello D., Eccher C., Betterle C. Long term thyroid function after thyroidectomy for Graves’ disease. J. Endocrinol. Invest. 77:371, 1988.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sugino, K., Mimura, T., Toshima, K. et al. Follow-up evaluation of patients with Graves’ disease treated by subtotal thyroidectomy and risk factor analysis for postoperative thyroid dysfunction. J Endocrinol Invest 16, 195–199 (1993). https://doi.org/10.1007/BF03344945
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03344945